|
KR101628872B1
(ko)
|
2014-05-28 |
2016-06-09 |
주식회사 레고켐 바이오사이언스 |
자가-희생 기를 포함하는 화합물
|
|
EP3160513B1
(en)
|
2014-06-30 |
2020-02-12 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
WO2016141230A1
(en)
|
2015-03-05 |
2016-09-09 |
Sirenas Llc |
Cyclic peptide analogs and conjugates thereof
|
|
CN107847605B
(zh)
|
2015-11-25 |
2021-12-24 |
乐高化学生物科学股份有限公司 |
包含分支接头的抗体-药物缀合物及其相关方法
|
|
CN108136038A
(zh)
|
2015-11-25 |
2018-06-08 |
乐高化学生物科学股份有限公司 |
包含肽基团的缀合物及其相关方法
|
|
CA3006242A1
(en)
|
2015-11-25 |
2017-06-01 |
Legochem Biosciences, Inc. |
Conjugates comprising self-immolative groups and methods related thereto
|
|
AU2017238246B2
(en)
*
|
2016-03-24 |
2021-04-01 |
The Administrators Of The Tulane Educational Fund |
Conjugates of tacrolimus, their compositions, and their uses
|
|
US11844839B2
(en)
|
2016-03-25 |
2023-12-19 |
Seagen Inc. |
Process for the preparation of pegylated drug-linkers and intermediates thereof
|
|
EP3474901B1
(en)
|
2016-06-27 |
2025-08-06 |
Tagworks Pharmaceuticals B.V. |
Cleavable tetrazine used in bio-orthogonal drug activation
|
|
TWI851531B
(zh)
|
2016-08-09 |
2024-08-11 |
美商思進公司 |
具有改善之生理化學性質之具自我穩定連接子之藥物結合物
|
|
WO2018045245A1
(en)
|
2016-09-02 |
2018-03-08 |
Sirenas Llc |
Cyclic peptide analogs and conjugates thereof
|
|
TWI835714B
(zh)
|
2016-10-18 |
2024-03-21 |
美商思進公司 |
菸鹼醯胺腺嘌呤二核苷酸補救合成(salvage pathway)抑制劑之靶向投遞
|
|
KR20250044934A
(ko)
|
2016-10-19 |
2025-04-01 |
인벤라 인코포레이티드 |
항체 구조물
|
|
FR3060567B1
(fr)
*
|
2016-12-19 |
2019-05-24 |
Ecole Normale Superieure De Lyon |
Substrat de glycosidase fluorogene et procede de detection associe
|
|
MX2019007019A
(es)
|
2016-12-22 |
2019-08-16 |
Univ Degli Studi Magna Graecia Catanzaro |
Anticuerpo monoclonal dirigido a un epitope de cd43 sialoglicosilado especifico asociado al cancer.
|
|
WO2018124758A2
(ko)
*
|
2016-12-28 |
2018-07-05 |
주식회사 인투셀 |
베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
|
|
KR102085798B1
(ko)
|
2016-12-28 |
2020-03-06 |
주식회사 인투셀 |
베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
|
|
EP3589328A1
(en)
|
2017-02-28 |
2020-01-08 |
Immunogen, Inc. |
Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
|
|
JP7152408B2
(ja)
*
|
2017-03-10 |
2022-10-12 |
キアペグ ファーマシューティカルズ アクチエボラグ |
遊離可能コンジュゲート
|
|
JP7527787B2
(ja)
|
2017-03-24 |
2024-08-05 |
シージェン インコーポレイテッド |
グルクロニド薬物－リンカーの調製のためのプロセスおよびその中間体
|
|
JP7664680B2
(ja)
|
2017-03-29 |
2025-04-18 |
リガケム バイオサイエンシズ， インク． |
ピロロベンゾジアゼピン二量体前駆体及びそのリガンド－リンカーコンジュゲート化合物
|
|
BR112019022445A2
(pt)
|
2017-04-27 |
2020-05-12 |
Seattle Genetics, Inc. |
Composição de conjugado ligante-fármaco, formulação, método para inibir a multiplicação de uma célula tumoral ou célula cancerosa ou causar apoptose em uma célula tumoral ou cancerosa, e, composto de conector de fármaco
|
|
CA3061907A1
(en)
*
|
2017-05-02 |
2018-11-08 |
Revolution Medicines, Inc. |
Rapamycin analogs as mtor inhibitors
|
|
US11707531B2
(en)
|
2017-09-11 |
2023-07-25 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
WO2019051488A1
(en)
|
2017-09-11 |
2019-03-14 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
|
|
MX2020003125A
(es)
|
2017-09-29 |
2020-10-01 |
Daiichi Sankyo Co Ltd |
Conjugado de anticuerpo-derivado de pirrolobenzodiazepina.
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
JP2021500391A
(ja)
|
2017-10-24 |
2021-01-07 |
マジェンタ セラピューティクス インコーポレイテッドＭａｇｅｎｔａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
Ｃｄ１１７＋細胞を減少させるための組成物及び方法
|
|
MX2020004910A
(es)
|
2017-11-29 |
2020-10-05 |
Magenta Therapeutics Inc |
Composiciones y métodos para el agotamiento de células cd5 +.
|
|
WO2019118884A1
(en)
|
2017-12-15 |
2019-06-20 |
Silverback Therapeutics, Inc. |
Antibody construct-drug conjugate for the treatment of hepatitis
|
|
WO2019121734A1
(en)
*
|
2017-12-21 |
2019-06-27 |
Pharmacytics B.V. |
Method for improving the oral bioavailability of a drug
|
|
TWI820077B
(zh)
|
2018-01-05 |
2023-11-01 |
美商斯布雷克薩一號公司 |
治療涉及酸性或缺氧性患病組織之疾病之化合物、組合物及方法
|
|
AU2019232652B2
(en)
*
|
2018-03-09 |
2022-04-21 |
Quiapeg Pharmaceuticals Ab |
Releasable antibody conjugates
|
|
MX2020010458A
(es)
*
|
2018-04-06 |
2021-01-29 |
Seattle Genetics Inc |
Conjugados de camptotecina-peptido.
|
|
MX2020011564A
(es)
|
2018-05-01 |
2021-01-29 |
Revolution Medicines Inc |
Analogos de rapamicina unidos a c26 como inhibidores de mtor.
|
|
AU2019262978B2
(en)
|
2018-05-01 |
2023-07-13 |
Revolution Medicines, Inc. |
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
|
|
WO2019215510A2
(en)
|
2018-05-09 |
2019-11-14 |
Legochem Biosciences, Inc. |
Compositions and methods related to anti-cd19 antibody drug conjugates
|
|
US20190375732A1
(en)
*
|
2018-05-14 |
2019-12-12 |
David Hung |
Anti-cancer nuclear hormone receptor-targeting compounds
|
|
CN120795120A
(zh)
|
2018-06-05 |
2025-10-17 |
伦敦大学国王学院 |
向胃肠系统递送酬载的btnl3/8导引构建体
|
|
TWI851577B
(zh)
|
2018-06-07 |
2024-08-11 |
美商思進公司 |
喜樹鹼結合物
|
|
JP2021532116A
(ja)
|
2018-07-23 |
2021-11-25 |
マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. |
同種異系の細胞療法における抗−ｃｄ５抗体薬物コンジュゲート（ａｄｃ）の使用
|
|
CN112955216A
(zh)
*
|
2018-09-12 |
2021-06-11 |
奎亚培格制药公司 |
可释放glp-1缀合物
|
|
CN113166113A
(zh)
|
2018-09-12 |
2021-07-23 |
希沃尔拜克治疗公司 |
取代的苯并氮杂䓬化合物、缀合物及其用途
|
|
MA53765B2
(fr)
|
2018-12-21 |
2025-04-30 |
Regeneron Pharmaceuticals, Inc. |
Tubulysines et conjugués tubulysines-protéines
|
|
CA3137373A1
(en)
|
2019-04-24 |
2020-10-29 |
Heidelberg Pharma Research Gmbh |
Amatoxin antibody-drug conjugates and uses thereof
|
|
KR20220008869A
(ko)
|
2019-05-14 |
2022-01-21 |
누베이션 바이오 인크. |
항암 핵 호르몬 수용체-표적화 화합물
|
|
KR20220051332A
(ko)
|
2019-07-10 |
2022-04-26 |
싸이브렉사 3, 인크. |
치료제로서의 미세소관 표적화제의 펩티드 접합체
|
|
KR20220052918A
(ko)
|
2019-07-10 |
2022-04-28 |
싸이브렉사 2, 인크. |
치료제로서의 사이토톡신의 펩티드 접합체
|
|
BR112022002720A2
(pt)
|
2019-08-15 |
2022-10-11 |
Silverback Therapeutics Inc |
Formulações de conjugados de benzazepinas e usos das mesmas
|
|
KR20210028544A
(ko)
|
2019-09-04 |
2021-03-12 |
주식회사 레고켐 바이오사이언스 |
인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도
|
|
KR20220079606A
(ko)
*
|
2019-10-04 |
2022-06-13 |
씨젠 인크. |
캄프토테신 펩티드 접합체
|
|
US20210130473A1
(en)
|
2019-10-09 |
2021-05-06 |
Silverback Therapeutics, Inc. |
TGFßR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOF
|
|
WO2021072330A1
(en)
|
2019-10-09 |
2021-04-15 |
Silverback Therapeutics, Inc. |
Galnac-tgfbr1 inhibitor conjugates for the treatment of liver diseases
|
|
US12502440B2
(en)
|
2019-11-08 |
2025-12-23 |
North Carolina State University |
Cross-linking compounds and methods of use thereof
|
|
US11952349B2
(en)
|
2019-11-13 |
2024-04-09 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
|
CN110974975B
(zh)
*
|
2019-12-12 |
2023-10-20 |
成都百利多特生物药业有限责任公司 |
一种快速释放的抗体药物偶联物
|
|
AU2020479745A1
(en)
*
|
2020-12-04 |
2023-07-20 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
Antibody-drug conjugate, and intermediate thereof, preparation method therefor, and application thereof
|
|
US20240058463A1
(en)
*
|
2020-12-18 |
2024-02-22 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
B7-h3 targeting antibody-drug conjugate, and preparation method therefor and use thereof
|
|
AU2020482223A1
(en)
*
|
2020-12-18 |
2023-07-27 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
Trop2 targeting antibody-drug conjugate, and preparation method and use therefor
|
|
US20220193251A1
(en)
|
2020-12-23 |
2022-06-23 |
Ludwig-Maximilians-Universitaet Muenchen |
Cd30 targeting antibody drug conjugates and uses thereof
|
|
IL306010A
(en)
|
2021-03-23 |
2023-11-01 |
Nuvation Bio Inc |
Anticancer compounds against the nuclear hormone receptor
|
|
EP4319755A4
(en)
|
2021-04-08 |
2025-03-26 |
Board of Regents, The University of Texas System |
Compounds and methods for theranostic targeting of parp activity
|
|
CA3215049A1
(en)
|
2021-04-10 |
2022-10-13 |
Baiteng ZHAO |
Folr1 binding agents, conjugates thereof and methods of using the same
|
|
AU2022262644A1
(en)
|
2021-04-23 |
2023-11-09 |
Genmab A/S |
Anti-cd70 antibodies, conjugates thereof and methods of using the same
|
|
WO2022235585A1
(en)
|
2021-05-03 |
2022-11-10 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
|
TW202320857A
(zh)
|
2021-07-06 |
2023-06-01 |
美商普方生物製藥美國公司 |
連接子、藥物連接子及其結合物及其使用方法
|
|
US11806405B1
(en)
|
2021-07-19 |
2023-11-07 |
Zeno Management, Inc. |
Immunoconjugates and methods
|
|
KR20240051956A
(ko)
|
2021-09-03 |
2024-04-22 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
|
EP4433096A1
(en)
|
2021-11-19 |
2024-09-25 |
Ardeagen Corporation |
Gpc3 binding agents, conjugates thereof and methods of using the same
|
|
WO2023131219A1
(en)
*
|
2022-01-06 |
2023-07-13 |
Virtuoso Binco, Inc. |
Conjugates, compositions and methods of use
|
|
WO2023194539A1
(en)
|
2022-04-07 |
2023-10-12 |
Heidelberg Pharma Research Gmbh |
Methods of improving the therapeutic index of amatoxin-antibody conjugates
|
|
CA3256390A1
(en)
|
2022-05-25 |
2023-11-30 |
Revolution Medicines, Inc. |
CANCER TREATMENT METHODS USING AN MTOR INHIBITOR
|
|
WO2024005123A1
(ja)
|
2022-06-30 |
2024-01-04 |
東レ株式会社 |
癌の治療及び／又は予防用医薬組成物
|
|
WO2024025396A1
(ko)
*
|
2022-07-28 |
2024-02-01 |
주식회사 레고켐 바이오사이언스 |
신규 오리스타틴 전구약물
|
|
CA3261509A1
(en)
|
2022-09-09 |
2024-03-14 |
Imperial College Innovations Limited |
CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
|
|
IL319811A
(en)
*
|
2022-09-30 |
2025-05-01 |
Systimmune Inc |
Auristatin drug with a highly stable hydrophilic linking unit and its conjugation
|
|
WO2024121632A1
(en)
|
2022-12-09 |
2024-06-13 |
Crispr Therapeutics Ag |
Use of anti-cd117 antibody drug conjugate (adc)
|
|
KR20250152101A
(ko)
|
2023-03-13 |
2025-10-22 |
하이델베르크 파마 리서치 게엠베하 |
암 치료에의 사용을 위한 피하 투여 항체-약물 접합체
|
|
KR20240159447A
(ko)
|
2023-04-28 |
2024-11-05 |
주식회사 에이비켐바이오 |
말레이미드 함유 링커-페이로드 접합체
|
|
KR20240159448A
(ko)
|
2023-04-28 |
2024-11-05 |
주식회사 에이비켐바이오 |
균일한 dar를 갖는 신규한 항체-약물 중합체의 제조방법
|
|
KR20250074353A
(ko)
|
2023-11-20 |
2025-05-27 |
주식회사 에이비켐바이오 |
높은 dar를 갖는 신규한 항체-약물 중합체, 이의 제조방법 및 이의 용도
|
|
US20240423620A1
(en)
|
2023-06-22 |
2024-12-26 |
Cilag Gmbh International |
Compressible surgical adjuncts, cartridges, and cartridge assemblies and methods of making surgical adjuncts
|
|
WO2024261662A1
(en)
*
|
2023-06-22 |
2024-12-26 |
Cilag Gmbh International |
Systems and methods for embedding medical additives into bioabsorbable materials
|
|
WO2025027529A1
(en)
|
2023-07-31 |
2025-02-06 |
Advesya |
Anti-il-1rap antibody drug conjugates and methods of use thereof
|
|
CN119424671A
(zh)
*
|
2023-08-01 |
2025-02-14 |
上海新理念生物医药科技有限公司 |
含糖基吡啶型连接子的抗体药物偶联物
|
|
WO2025072406A1
(en)
|
2023-09-26 |
2025-04-03 |
Profoundbio Us Co. |
Ptk7 binding agents, conjugates thereof and methods of using the same
|
|
WO2025126157A1
(en)
|
2023-12-15 |
2025-06-19 |
Advesya |
Anti-il-1rap binding domains and antibody-drug conjugates thereof
|
|
WO2025149661A1
(en)
|
2024-01-10 |
2025-07-17 |
Genmab A/S |
Slitrk6 binding agents, conjugates thereof and methods of using the same
|
|
WO2025171055A1
(en)
|
2024-02-06 |
2025-08-14 |
Kumquat Biosciences Inc. |
Heterocyclic conjugates and uses thereof
|
|
US20250381289A1
(en)
|
2024-02-29 |
2025-12-18 |
Genmab A/S |
Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same
|